Disclosed is a method for enhancing the effectiveness of tamoxifen in the prevention and treatment of hormone-associated cancer such as breast cancer. Also disclosed is a method for decreasing the risk of endometrial hyperplasia and endometrial cancer associated with tamoxifen therapy. In the method, tamoxifen therapy is combined with administration of daidzein or its equol metabolite.